A35 is a novel synthetic cyclizing-berberine recently patented as an antitumor compound. Based on its dual targeting topoisomerase (top) activity, A35 might overcome the resistance of single-target top inhibit...
from Cancer via ola Kala on Inoreader https://ift.tt/2jvoTUo
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου